WGS of Group-B Streptococcus (GBS) from Bangladesh
Group B Streptococcus (GBS, a.k.a. Streptococcus agalactiae) is an opportunistic pathogen and a major cause of neonatal invasive disease, with a particular impact on infant mortality in low- and middle-income countries (LMICs). In collaboration with the Wellcome Sanger Institute under the JUNO project (a global genomic survey of Streptococcus agalactiae), the Child Health Research Foundation in Bangladesh conducted whole-genomic sequencing of 489 GBS isolates from a range of sample sources, including blood, urine, nasopharyngeal swabs, skin swabs, vaginal swabs, and rectal swabs.
Group B Streptococcus (GBS, a.k.a. Streptococcus agalactiae) is an opportunistic pathogen and a major cause of neonatal invasive disease, with a particular impact on infant mortality in low- and middle-income countries (LMICs). In collaboration with the Wellcome Sanger Institute under the JUNO project (a global genomic survey of Streptococcus agalactiae), the Child Health Research Foundation in Bangladesh conducted whole-genomic sequencing of 489 GBS isolates from a range of sample sources, including blood, urine, nasopharyngeal swabs, skin swabs, vaginal swabs, and rectal swabs.